Aluminum Chloride Anhydrous

Summary

Aluminum Chloride Anhydrous (CHEMBL3833401) is an approved small-molecule Lewis acid.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 133.34 Da · AlCl3

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL3833401
Name	Aluminum Chloride Anhydrous
Type	Small molecule
Max phase	4
FDA approved	yes
PubChem CID	24012
ChEBI	CHEBI:30114
Molecular formula	AlCl3
Molecular weight	133.34
InChIKey	VSCWAEJMTAWNJL-UHFFFAOYSA-K

SMILES: [Al](Cl)(Cl)Cl

IUPAC name: trichloroalumane

Pharmacological roles (ChEBI): Lewis acid.

Parent form; salt/anhydrous children: CHEMBL3833314

Patent coverage: 175,178 distinct patent families (380,500 SureChEMBL compound mentions), from 2 matched compound structure(s). One matched structure accounts for 269,812 (71%) of the total. Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indications (0 at ChEMBL trial phase 4).

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).